Equities

Apyx Medical Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Apyx Medical Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)3.92
  • Today's Change-0.06 / -1.51%
  • Shares traded36.35k
  • 1 Year change+180.00%
  • Beta1.5832
Data delayed at least 15 minutes, as of Feb 11 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Apyx Medical, Inc., formerly Apyx Medical Corporation, is a surgical aesthetics company. Its segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment’s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment, designs, develops and manufactures electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs.

  • Revenue in USD (TTM)47.90m
  • Net income in USD-14.54m
  • Incorporated1982
  • Employees220.00
  • Location
    Apyx Medical Corp5115 Ulmerton RoadCLEARWATER 33760United StatesUSA
  • Phone+1 (727) 384-2323
  • Fax+1 (631) 421-5821
  • Websitehttps://apyxmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cibus Inc3.79m-118.90m135.80m157.00--2.09--35.79-3.26-3.260.09720.95880.0109--4.2324,165.61-36.11-80.24-39.32-89.98-----3,322.54-1,268.46---2.180.8131--134.56-10.196.07---22.92--
Fonar Corp105.43m6.99m137.54m535.0017.960.70099.801.301.041.0415.7426.690.489722.331.28197,073.504.346.774.427.1941.0745.468.8613.748.46--0.0021--1.434.02-21.260.1719-12.96--
LifeMD Inc252.34m-7.71m146.81m304.00--108.1129.730.5818-0.1711-0.17115.660.02823.6410.8333.00830,075.60-4.29-109.71-31.14-396.0386.9685.59-1.18-33.120.66450.31640.00--39.2776.327.23------
LENSAR Inc59.14m-51.52m148.47m140.00------2.51-4.39-4.394.99-1.020.89461.7911.51422,435.70-77.94-32.69-121.49-38.9546.1551.51-87.12-54.770.6671------26.8711.87-118.34---40.48--
Anika Therapeutics Inc82.20m13.91m148.97m288.0010.971.017.371.810.9419-2.285.7010.180.39070.4863.25285,430.606.61-1.877.39-2.0654.2960.7416.92-4.734.47--0.00---0.73270.9077-156.70--24.14--
InfuSystem Holdings Inc141.05m5.52m154.76m502.0029.092.798.171.100.26160.26166.652.731.3810.255.79280,984.105.414.506.565.4655.3555.243.923.861.607.730.2740.007.2210.70168.9211.50-4.62--
Inogen Inc347.03m-25.38m156.10m766.00--0.7917--0.4498-1.00-1.0013.477.261.137.929.30453,039.20-8.28-11.40-10.67-13.5044.7644.22-7.31-13.822.75--0.00--6.35-1.4964.97--38.15--
Lucid Diagnostics Inc4.40m-65.84m158.42m72.00------36.01-0.8968-0.89680.05260.19730.116112.2414.9461,097.22-140.60-139.37-301.55-297.39-58.13---1,211.30-2,492.791.88--0.4633--79.00---0.6817------
Citrine Global Corp0.00-1.74m160.44m18.00---------0.0016-0.00160.00-0.00310.00----0.00-118.80-238.43-----------186,483.40---2.10--------25.99------
Apyx Medical Inc47.90m-14.54m163.24m220.00--25.74--3.41-0.3644-0.36441.190.15460.81131.973.68217,736.40-24.60-27.67-29.90-33.3562.6564.81-30.32-43.613.61-2.040.8507---8.1111.24-25.38---11.11--
Nano-X Imaging Ltd12.30m-55.71m164.72m165.00--0.993--13.39-0.8839-0.88390.1952.400.068313.177.1874,557.58-30.95-28.17-33.30-31.20-98.04---452.82-1,072.253.93--0.0201--13.91--11.95--85.79--
Acme United Corp194.96m10.02m167.50m633.0018.081.4510.310.85912.432.4347.3530.411.152.036.35307,993.705.927.266.818.5439.5136.345.145.681.758.570.196218.401.566.42-43.6712.7033.594.56
Edap Tms SA (ADR)75.88m-23.35m171.73m310.00--6.19--2.26-0.6235-0.62352.020.74180.90812.083.62244,774.70-27.94-11.18-49.24-15.8643.2442.19-30.77-16.630.9729--0.2062--6.117.3810.20--55.92--
CVRx Inc55.97m-52.02m175.35m206.00--3.65--3.13-2.02-2.022.181.830.46840.74586.49271,694.20-43.53-37.08-47.98-40.0284.4981.33-92.95-151.188.60-8.490.5072--30.5352.31-45.55--66.61--
Rapid Micro Biosystems Inc30.52m-44.29m180.84m163.00--4.08--5.92-0.9984-0.99840.68841.000.32091.336.40187,257.70-46.56-38.13-56.14-43.367.72-27.98-145.11-253.022.95--0.3003--24.5711.1810.63---4.24--
Accendra Health Inc6.71bn-410.53m184.08m13.50k------0.0275-5.33-17.4186.97-5.561.477.5915.52496,837.20-9.01-0.3346-17.40-0.524826.1318.20-6.12-0.1460.83861.671.25--3.553.04-778.15--34.30--
Data as of Feb 11 2026. Currency figures normalised to Apyx Medical Corp's reporting currency: US Dollar USD

Institutional shareholders

35.99%Per cent of shares held by top holders
HolderShares% Held
Nantahala Capital Management LLCas of 30 Sep 20253.34m8.14%
Archon Capital Management LLCas of 30 Sep 20253.28m8.00%
Royce & Associates LPas of 31 Dec 20252.44m5.95%
The Vanguard Group, Inc.as of 31 Dec 20251.35m3.30%
AIGH Capital Management LLCas of 31 Dec 20251.10m2.69%
Silverberg Bernstein Capital Management LLCas of 31 Dec 20251.03m2.52%
Commonwealth Equity Services LLCas of 30 Sep 2025663.54k1.62%
Horizon Kinetics Asset Management LLCas of 30 Sep 2025615.00k1.50%
BlackRock Fund Advisorsas of 30 Sep 2025498.75k1.22%
Taylor Frigon Capital Management LLCas of 31 Dec 2025437.96k1.07%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.